- Home
- ICLR vs GFS Comparison
ICLR vs GFS Comparison
Compare ICLR & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- GFS
- Stock Information
- Founded
- ICLR 1990
- GFS 2009
- Country
- ICLR Ireland
- GFS United States
- Employees
- ICLR 41100
- GFS N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- GFS Semiconductors
- Sector
- ICLR Health Care
- GFS Technology
- Exchange
- ICLR Nasdaq
- GFS Nasdaq
- Market Cap
- ICLR 24.3B
- GFS 22.6B
- IPO Year
- ICLR 1998
- GFS 2021
- Fundamental
- Price
- ICLR $293.54
- GFS $39.65
- Analyst Decision
- ICLR Strong Buy
- GFS Buy
- Analyst Count
- ICLR 10
- GFS 13
- Target Price
- ICLR $351.60
- GFS $58.25
- AVG Volume (30 Days)
- ICLR 824.8K
- GFS 1.3M
- Earning Date
- ICLR 10-23-2024
- GFS 11-05-2024
- Dividend Yield
- ICLR N/A
- GFS N/A
- EPS Growth
- ICLR 39.27
- GFS N/A
- EPS
- ICLR 8.61
- GFS 1.46
- Revenue
- ICLR $8,331,892,000.00
- GFS $6,887,000,000.00
- Revenue This Year
- ICLR $6.84
- GFS N/A
- Revenue Next Year
- ICLR $8.10
- GFS $13.38
- P/E Ratio
- ICLR $34.07
- GFS $26.68
- Revenue Growth
- ICLR 5.42
- GFS N/A
- 52 Week Low
- ICLR $221.20
- GFS $38.45
- 52 Week High
- ICLR $347.72
- GFS $62.61
- Technical
- Relative Strength Index (RSI)
- ICLR 45.56
- GFS 44.05
- Support Level
- ICLR $280.96
- GFS $38.45
- Resistance Level
- ICLR $305.14
- GFS $41.73
- Average True Range (ATR)
- ICLR 8.88
- GFS 1.30
- MACD
- ICLR 0.83
- GFS 0.23
- Stochastic Oscillator
- ICLR 42.53
- GFS 36.59
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About GFS GlobalFoundries Inc.
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 12,000 people.